Other news
![RTM added as distributor NeuraCeq®](https://radboudtranslationalmedicine.nl/cdn/c23b15a6-eef5-4843-a143-f51c61ba0b6a/-/smart_resize/250x170/-/format/auto/-/quality/smart/neuraceq.png)
RTM added as distributor NeuraCeq®
Exciting news! Life Molecular Imaging’s NeuraCeq® 300 MBq/ml solution for injection (florbetaben 18F...
![First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer](https://radboudtranslationalmedicine.nl/cdn/6bac4557-a1f4-4d63-9b07-9644f2141bfa/-/smart_resize/250x170/-/format/auto/-/quality/smart/telix-nieuwsbericht.jpg)
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
The below product is manufactured at RTM First Patient Dosed in Phase II Study of TLX250-CDx in Tri...
![First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer](https://radboudtranslationalmedicine.nl/cdn/6bac4557-a1f4-4d63-9b07-9644f2141bfa/-/smart_resize/250x170/-/format/auto/-/quality/smart/telix-nieuwsbericht.jpg)
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
The below product is manufactured at RTM First Patient Dosed in Phase II Study of TLX250-CDx in Tri...
![Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers](https://radboudtranslationalmedicine.nl/cdn/3b3bec47-866e-401d-a8d4-0344b20a02a3/-/smart_resize/250x170/-/format/auto/-/quality/smart/page-1-article-kc.jpg)
Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Klaudia Cybulska (postdoc radiochemistry) has written an article about Huntington's Disease. Abstra...
Interested in a collaboration?
Contact us to discuss the possibilities.